Roche Diagnostics sees genomics tools maturing rapidly; proteomics not so much

We asked Roche Diagnostics’ Director of Innovation Concept Development Jochen Hurlebaus about the role of new technologies in diagnostics at the 2009 Molecular Medicine Tri-Conference in San Francisco. Jochen had said in a presentation that “everything at Roche is moving towards personalized healthc...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Oxford Nanopore prepares for a $3 billion IPO

News Commentary | April 01, 2021

Oxford Nanopore's nanopore technology has come into the limelight since the COVID‑19 outbreak. Since then, it has supported scientists in over 85 countries in tracking the emergence of new mutant variants. This field validation and its ability to overcome various technical hurdles sets the stage for... To read more, click here.

Helix's pivot from consumer genomics to population genomics highlights broader shifts in the human genomics landscape

Case Study | July 29, 2021

Helix Genomics came into the spotlight a few years ago when it pioneered a digital marketplace concept for genomics where it used a dynamic consent model to allow third‑party developers to turn genomics data into personalized insights for the consumer. It also offered whole‑exome sequencing (WES), ... Not part of subscription

Human Genomics

Technology | August 25, 2021

The sequencing, analysis, and interpretation of the human genome, which leads to therapeutic, diagnostic, and wellness applications. Not part of subscription